Clinical Trial

Circumferential Pulmonary Vein Isolation Plus Transition Zone Modification in Atrial Fibrillation Patients Without Low-Voltage Areas

Study acronym: PVI-TZM-AF
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study investigates two treatments for atrial fibrillation (AF) patients without low-voltage-areas (LVAs). It aims to determine whether adding transition zone modification (TZM) to the pulmonary vein isolation (PVI) improves long-term outcomes compared to PVI alone.
Trial Details
NCT Number NCT06930599
Lead Sponsor The First Affiliated Hospital with Nanjing Medical University
Conditions Atrial Fibrillation (AF)
Enrollment 162 participants
Start Date 2025-04-09
Primary Completion 2026-10-09 (estimated)
Study Completion 2026-10-09 (estimated)
Updated on ClinicalTrials.gov 2025-04-16